Two-minute interpretation
Enter the organism and susceptibility panel; DxTiba returns a ranked recommendation in under two minutes instead of a 20–30 minute manual lookup.
Everything between the lab result and the prescription.
DxTiba is a clinical decision-support layer, not a diagnostic device and not an EMR replacement. It does one job: turn a susceptibility result into a guideline-aligned recommendation the clinician can act on immediately.
Guideline mapping
Every result is mapped against Kenya's national treatment guidelines and the WHO AWaRe classification, with the source clause shown beside the recommendation.
Local antibiogram aware
Configured to the resistance patterns and formulary of the hospital it runs in, so recommendations reflect what is actually stocked and actually working.
Auditable, not a black box
Rules-based logic means every output can be traced, reviewed and challenged by your stewardship committee, a requirement for clinical trust.
Stewardship reporting
Turnaround time, guideline concordance and prescribing patterns captured as a by-product of use, shaped to report cleanly into GLASS-style surveillance.
Works on ward hardware
Designed for the phones and shared desktops clinicians already carry, with tolerance for the intermittent connectivity normal in Kenyan referral hospitals.
Built on the standards your clinicians already follow
Kenya NAP-AMRNational treatment guidelines
WHO AWaReAccess · Watch · Reserve
CLSI / EUCASTSusceptibility breakpoints
GLASS-readySurveillance-shaped data
A recommendation that shows its work.
The clinician sees the isolate, the full susceptibility panel and the ranked options (first line, alternatives, and what to avoid), each tagged with its WHO AWaRe category and the guideline it comes from.
- Ranked first-line and alternative regimens
- WHO AWaRe Access / Watch / Reserve tagging
- Renal and paediatric dose flags
- De-escalation and review reminders at 48–72 hours
Isolate
Klebsiella pneumoniaeESBL+
Susceptibility
MeropenemS
AmikacinS
CiprofloxacinI
CeftriaxoneR
Recommendation
1st Meropenem 1g IV q8h
Result → recommendation1 min 12 s
1.8 minMedian turnaround
96%Guideline concordance
134Results processed
Recommendations issuedMon – Sun
Evidence of practice, generated by normal use.
Stewardship committees are asked to prove what is happening on the wards using data nobody has time to collect. DxTiba captures it as a by-product: how fast results were acted on, how often the guideline was followed, and where resistance is moving.
Because the recommendation logic is explicit, the committee can review and change the rules themselves rather than filing a support ticket with a vendor.
Dashboard shown is an illustrative product view. The figures in it are sample data, not results from a hospital.
What DxTiba does, and what it deliberately does not.
What it does
- Interprets susceptibility results your lab already produces
- Maps them to current national and WHO guidance
- Ranks treatment options with dosing and AWaRe class
- Records the decision trail for stewardship review
What it does not do
- It does not run or replace the laboratory test
- It does not diagnose the infection
- It does not prescribe. The clinician decides, always
- It does not use an opaque predictive model
Want to pressure-test this on your ward?
The fastest way to tell whether DxTiba is useful is to watch a clinician use it on real results. We are looking for wards willing to try exactly that.